Skip to main content
Fig. 2 | BMC Health Services Research

Fig. 2

From: Economic assessment of incorporating the hexavalent vaccine as part of the National Immunization Program of Peru

Fig. 2

One way sensitive analysis. Variation in estimated total annual costs for the payer (USD, $) when modifying the hexavalent vaccine acquisition cost per dose. USD, $1 equal to S/ 3.374 Peruvian Soles (average accounting exchange rate reported on December 31, 2018 by the Peruvian Superintendence of Banks, Insurance and Private Pension Fund Administrators [Superintendencia de Banca, Seguros y AFP]).[36]. USD, US dollar

Back to article page